Across TCGA pan-cancer cohorts, BTF3P13 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated BTF3P13 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher BTF3P13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BTF3P13 expression acts as an unfavorable survival marker, although some lineages such as COAD and UCS show a favorable association.

CHOL, STAD, and COAD are the cancer types where BTF3P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Median	III,IV	0.286	1.000	.008	48	view →
STAD	OS	Tertile	All	0.511	0.749	.005	45	view →
COAD	DFS	Quartile	All	0.677	0.368	.005	42	view →
MESO	DFS	Quartile	IV	0.079	0.473	.002	37	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
ACC	OS	Median	II,III,IV	0.230	0.700	.002	25	view →
OV	DFS	Tertile	IV	0.605	0.326	.004	18	view →
THYM	OS	Tertile	IV	0.294	1.000	.025	18	view →
LUAD	OS	Tertile	III,IV	0.470	0.831	.001	15	view →
KIRP	DFS	Quartile	All	0.823	0.944	.002	13	view →
PCPG	DFS	Quartile	All	0.813	0.945	.006	13	view →
UVM	DFS	Quartile	All	0.402	0.912	.006	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 28 lineages.

Exploration

Same gene, other analysis: BTF3P13 tumor-vs-normal RNA expression · all BTF3P13 data types